2014-11-07如何撰写一篇SCI综述-SCI review writing-2014.ppt

如何撰写一篇SCI综述？Howtowriteareview?InstitutesofBiologyandMedicalSciencesSoochowUniversity,2014.11.7,1.Whatdoesthejournalwant？2.Whatdoesthereviewerwant？3.Whatdoreaderswant？,Beforewritingthepaper,1.Whatdoesthejournalwant？,Aimandscopeofthejournal,杂志的定位、范畴与文体,影响因子、发行频率、收费（审稿费、版面费、彩图费）,Impactfactor,frequency,andfeeofthejournal,简讯,学术论文,评论,综述,简报,通讯,Aimandscopeofthejournal,杂志的定位、范畴与文体,ImpactFactor:32.438(2013),研究报告,学术论文,评论,观点（综述）,科学院研讨会,读者来信（争议）,ImpactFactor:9.737(2013),影响因子、发行频率、收费（审稿费、版面费、彩图费）,Impactfactor,frequency,andfeeofthejournal,PNAS,ImpactFactor:5.788(2012),thereviewersaretheexperts(andcompetitors)inthesamefield！he/shemayhavecompetitiveinterestwithyou!Trytoavoidthat.Mustciteallimportantliteratures!Especiallythosewrittenbytheauthoritiesofyourfield.,2.Whatdoesthereviewerwant？,Howtomeetthedemandofpotentialreviewers?,EstablishONEcentralthemeofwhatyouwanttotellthereadersorreviewers.makea“sexy”(butwithabsolutelynoexaggeration)titletoattractreviewersinterest.Explainandrationalizeeveryparameterandeverysinglestepemployed.Reviewersdonothavetimetothinkaboutdetails.Confirmallthingspresentedaredetailedenoughforonetoreproduceyourwork.Donotskipanydetail.Bepersuasive!Doacomprehensiveratherthanahalf-finishedstudy!Trytoproveyourcentralthemefrommultipletests/sources.Citeallimportantstudies.,明确中心主题,标题诱人但恰如其分,所有参数规范合理（材料方法路线）,足够详细可供重复试验,多种方法资料充分证实,引用该领域所有近年权威文献！,Readershaveadiverselevelofexpertiseinyourfield(frombeginners(graduatestudents)towell-establishedexperts).Thus,thepapershouldbesimpleenoughtomakeitunderstandableandreproduciblebygraduatestudentsanddeepenoughtoattractinterestsofexperts.Allscientistsareusuallyverybusy.Theyhopetofindthemostimportantinformationveryquickly.Aninterestingtitleandanabstractcontainingsignificantinnovationandinterestingfindingswillattractthemtoreadthepaper.Theyoftenskipparagraphsandreadwhatisofmostinteresttothem.Thus,writeawell-structured(linked),easilyunderstoodpaperisnecessary.,2.Whatdoreaderswant？,Howtomeetthedemandofreaders?,eachsentencemakesonlyonepoint,whichisemphasizedattheendoftheSentence。Eachparagraphonlytellonestoryaboutonesubject.Itshouldstartwithatopicsentenceandendwithasummaryortransitionsentenceforthenextparagraph.Sentencesshouldlogicallylinkeachother.captionsintablesandfigurescanbeunderstoodwithouttheneedofreadingthemaintext.Savethebestforthelast.,一句话只有一个主题，重心放于句末,每一段落围绕一个主题；以明确主题起头、以总结或者过渡结尾；句与句之间有逻辑联系。,图、表可直接看懂，一目了然,技巧：最重要数据放在表右栏、最末一行；图中以最醒目颜色或图示标记,1.Carefullyreadthegeneralguideline2.Preparethemanuscript,figurefile,coverletter3.Recommendseveralreviewers4.Submitincorrectprocedure,Preparethepaper,GeneralGuidelinesA12-pointseriffont,preferablyTimesNewRoman,isrequired.Double-spaceentiremanuscript.Eachofthefollowingcomponentsshouldbeginonaseparatepage:,1.TheTitlePage:fulltitle;arunningtitle(nottoexceed60characters);eachauthorsfullname,affiliationsofallauthorsandtheirinstitutions,departments,ororganizations(,|,#,*,|,#).Listthephonenumber,faxnumber,ande-mailaddressofthecorrespondingauthoronthetitlepage.2.TheAbstractmustbe250wordsorlessforFull-Lengthtypemanuscripts.ThespeciesofanimalsorspeciesoforiginofcellsmustbeclearlystatedintheAbstract.3.TheIntroduction,MaterialsandMethods,Results,andDiscussionsectionsshouldbeginonseparatepagesinthatorder.Forflowcytometryexperiments,authorsshouldspecifythegatingstrategiesintheMethodsorinthefigurelegend.4.AcknowledgmentsappearimmediatelyaftertheDiscussionandbeforeReferences.5.GrantsupportmustNOTbeincludedintheAcknowledgmentsbutshouldbecitedasafootnotetothetitle.6.Referencesmustbenumberedastheyappearinthetext.Allauthorsmustbelistedforeachreference.Formatforreferences:,Books:McIntyre,T.M.,andW.Strober.1999.Gut-associatedlymphoidtissue:regulationofIgAB-celldevelopment.InMucosalImmunology,2nded.P.L.Ogra,J.Mestecky,E.Lamm,W.Strober,J.Bienenstock,andJ.R.McGhee,eds.AcademicPress,SanDiego,CA.p.319356.Articlespublishedaheadofprint:Fraser,D.A.,A.K.Laust,E.L.Nelson,andA.J.Tenner.2009.C1qdifferentiallymodulatesphagocytosisandcytokineresponsesduringingestionofapoptoticcellsbyhumanmonocytes,macrophages,anddendriticcells.J.Immunol.doi:10.4049/jimmunol.0902232.,7.Footnotesshouldbeusedtodesignatethesourceofsupport,neworspecialabbreviationsused,correspondenceaddress,currentaddress,etc.8.Abbreviationsthatmaybeusedwithoutdefinitionareprovidedbelow.Spelloutnonstandardabbreviationsusedlessthanthreetimes.,9.TablesmustbenumberedwithRomannumeralsinorderofappearanceinthetext.Alltablesmusthaveatitle.Tablelegendsarepreparedasfootnotes.TablesmustbeinDOCfileformat.Eachtableshouldbesubmittedasaseparatefile.10.FigurelegendsmustbenumberedwithArabicnumeralsinorderofappearanceinthetextandshouldincludeashorttitleafterthefigurenumber.Allfigurelegendsmustspecifythenumberoftimeseachexperimentwasindependentlyperformed,aswellasthenumberofanimalsorreplicatesineachexperimentalgroup.Forflowcytometryexperiments,authorsshouldspecifythegatingstrategiesintheMethodsorinthefigurelegend.11.Figures:Atinitialsubmission,pleasesubmitlowresolutionfilesofthesmallestpossiblefilesizethatwillconveytheneededinformation.Smallerfilescanbedownloadedmorequicklybyreviewersandwillhastenthereviewprocess.Alternately,singlePDFoftextplusfiguresmaybesubmittedatinitialsubmission.Atsubmissionofarevisedmanuscript,high-resolutionfiguresthatmeetthefollowingspecificationsmustbesubmitted.1)Color:ColorfiguresmustbeintheRGBcolorspace.2)FileSizes:Figurefilesshouldnotexceed10MB(averagesizeisabout2MB).3)ImageSizes:Figuresshouldbesubmittedinfinalprintpublicationsize(printed1:1).Figuresmaybepublishedinprintinoneoftwoformats:single-column(widthfrom3.37to8.23cm)ordouble-column(widthfrom12.65to17.1cm).Thesingle-columnformatispreferred.4)TextandLines:Textinfiguresmustbe6-8pointsinsize,exceptforsinglelettermarkers,whichmaybe12points.HelveticaorArialshouldbeusedforallfiguretext(exceptfortheuseofsymbols).LinewidthsmustbegreaterthanonepointthickortheywillnotbevisibleonthePDFversion.5)Numbering:Figuresmustbenumberedastheyappearinthetext.6)FileFormat:FiguresshouldbeinTIFF(betterforhalftonearte.g.,blots,photographs)EPS(betterforlineartormonochromeart,i.e.,anythingthatinvolvessharplydelineatedlines),orPDFformat.PowerPointfilesarenotsuitablequality,astheirresolutionistoolowforprint.,HumanandAnimalUse:AllstudiesinvolvinghumansubjectsmustbeconductedinaccordancewiththeguidelinesoftheWorldMedicalAssociationsDeclarationofHelsinki(mostrecentrevision).AllanimalstudiesmustbeperformedincompliancewiththeU.S.DepartmentofHealthandHumanServicesGuidefortheCareandUseofLaboratoryAnimals(orotherwiserelevantguidelines).Astatementthathumanand/oranimalstudieshavebeenreviewedandapprovedbyanappropriateinstitutionalreviewcommitteemustbeincludedintheMaterialsandMethodssectionofthemanuscript.,DepositinginPublicDatabasesHigh-resolutionstructuraldata:requiresanaccessionnumberfromtheProteinDataBankandassurancethatunrestrictedreleasewilloccuratorbeforethetimeofpublication.Nucleotidesequences:Sequencesofnucleotidesoraminoacidslongerthan50bases/residuesshouldnotbepresentedinthetextorintableform,butrathershouldbesubmittedasapublication-qualityfigure.Originalnucleotidesequences,anddeterminednucleotidesequencesencodingreportedaminoacidsequences,describedinthemanuscriptmustbesubmittedtoGenBankorEMBLDataLibraryatthetimeofmanuscriptsubmission.Anaccessionnumberandsequenceavailabilityarerequiredatthetimeofpublication.MicroarrayData:TheJIwillnotpublishdescriptivemanuscriptsthatreportmicroarraydata,unlesssuchinformationcanbeconsideredofunusualimmunologicalsignificanceand/orincludefunctionalexperimentsthatprovidenovelinsightintomechanism.Aswithotherscientificapproaches,currentexperimental,quantitation,verification,pletemicroarraydatamustbedepositedintheappropriatepublicdatabase(e.g.,GEO,ArrayExpress,orCIBEX),andmustbeaccessiblewithoutrestrictionfromthedateofpublication.Anentrynameoraccessionnumbermustbeincludedinthepaperbeforepublication.,人类标本和动物使用,公共数据库使用,1.Carefullyreadthegeneralguideline2.Preparethemanuscript,figurefile,coverletter3.Recommendseveralreviewers4.Submitincorrectprocedure,Preparethepaper,PrearrangedEditors(PE).PriortosubmissiontoPNAS,anauthormayaskanNASmembertooverseethereviewprocessofaDirectSubmission.条件：whenanarticlefallsintoanareawithoutbroadrepresentationintheAcademy,orforresearchthatmaybeconsideredcountertoaprevailingviewortoofaraheadofitstimetoreceiveafairhearing,andinwhichthememberisexpert.theNASmemberwillbecontactedbythePNASOfficewithin3daysofsubmissiontoconfirmhisorherwillingnesstoserveasaPEandtogivesubstantivecommentontheimportanceofthework.TheBoardcannotguaranteethatthememberdesignatedbytheauthorwillbeassignedthemanuscriptorthatitwillbesentforreview.Thepapercouldberejectedwithoutrevieworbehandledbyanothermember.authorsarenotpermittedtocontactaneditordirectly.PaperswithaPEarepublishedwithafootnotetothateffect.AnNASmembermayserveasaPEonasmanyasfourpapersperyear.,PNAS,如何撰写一篇SCI综述？Howtowriteareview?,FutureMicrobiology.2012;7(10):1207-1216,WhatisaReview?,AReviewisanauthoritative,balancedandscholarlysurveyofrecentdevelopmentsinaresearchfield.Therequirementforbalanceneednotpreventauthorsfromproposingaspecificviewpoint,butiftherearecontroversiesinthefield,theauthorsmusttreattheminaneven-handedway.,权威性的，不偏不倚的，学术性集成的，最新进展,争议性学术观点：要客观端平,focusonaspecificfieldorsubfieldwithinalargerdisciplineanddiscusscurrentadvancesandfuturedirections.,最新进展研究发展方向,1.Whatdoesthejournalwant？,FindajournalwhichAimandscopeissuitableforyou,确定一个合适的刊登综述的杂志,综合期刊专职综述期刊,Notice:attheinvitationoftheeditorialboard(always),Step1:writeaproposaltoaskforpossibilityofsubmittingareview.,Step2:ProvidethemainachievementonthespecificfieldofyourgroupwithyourpublicationandCV.,Step3:Submitthemanuscriptaccordingtotheauthorguide.,Step4:Waiteforthereviewerscriticismandrevisethemanuscript.,Step5:modifythemanuscriptproof.,Scopeabimonthlyjournalprovidingthelatestinformationandadvancementsinourunderstandingoftheimmunologicalresponseofthehost,bothinvitroandinvivo.Thejournalcoverbothbasicresearchandclinicalapplicationsinallareasofcellularandmolecularimmunology,includingbutnotlimitedto:clinicalimmunologycomparativeimmunologyimmunobiologyimmunogeneticsimmunologicaltechniquesimmunopathology,immunopharmacologyinfectionimmunologyneuroimmunologytransplantationimmunologytumorimmunologyveterinaryimmunology,ImpactFactor:2.026（2012）3.419（2013）,Step1:writeaproposaltoaskforpossibilityofsubmittingareview.,DearDrXu,ManythanksforyourinterestinCellularbluntingsystemicorlocalTh1immunitycouldpreventortreatCVB3-myocardits.(JGeneMed.2008;10:918,PLoSOne.2011;6(3):e18186,MolImmunol.2011:48:706-713,ClinImmunol.2011;140(1):92);2)ChemokinesuchasMCP-1andIP-10arecriticalcytokinesexpressedinthemyocardialtissueduringtheearlyinfectionphasecontributingtotheintensiveinfiltrationofinflammatorymononuclearcellsinviralmyocarditis(VMC),interveningstrategiessuchasMCP-1orIP-10mutantgenetransfercouldameliorateCVB3-myocardis.(J.Virol.2004;78(22):12548,IranJAllergyAsthmaImmunol.2009;8(1):1,MolImmunol.2011:48:706,PLoSOne.2011;Mar22;6(3):e18186).OurlabisamongfewlabsthatfirstreportedthecriticalrolesofMCP-1intheinductionofCVB3-myocardits.3)Sex-biaseddifferentialmacrophagepolarizationinthemyocardialtissueduringCVB3infectionwasfirstreportedbyourgroupanddemonstratedtocontributetothedifferentialThpolarizationindifferentgenderofmice(CirculationRes.2009;105:353)whichisanovelfindingexplainingthesex-biasedpathogenicityofVMC.4)TodevelopnovelvaccinesagainsttheenterovirusCVB3andCVB3-myocarditis,chitosanformulatedmucosalDNAvaccinewasfirstreportedbyourlabtopreventthisdiseaseinmurinemodelandnovelenhancingstrategiessuchasmucosaladjuvantandco-administrationmeanswerethendevelopedwhichimprovedtheeffectofthismucosalvaccines(Vaccine.2004;22(27-28):3603,Virology.2009;386:438,DNACellBiol.2012;31(4):479).Ourfindinghasbeenselectedasoralpresentationatthe13thInternationalCongressofImmunology.Aug21-25,2007,RiodeJanrio,Brazil.oralpresenter(ControlNo.2007-A/P-1025-ICI.WeiXu,SidongXiong.Intranasaldeliveryofchitosan-DNAnanoparticlegeneratesmucosalSIgAandpreventsCVB3-inducedmyocarditiswhichcouldbeoptimizedbycombiningwithendosomalfusogenicpeptideorlymphotactin.)Belowareourmainpublicationsduringthese10years.YoucouldalsofindthebriefCVofDr.WeXUandDr.SidongXIONGforyourreference.HopeourachademicbackgroundandpublicationsinthefieldofviralmyocarditsmeettherequirementforreviewpapersubmissiontoCellularandMolecularImmunology.,Publications:,YueY,XuW,XiongS.ModulationofImmunogenicityandImmunoprotectionofMucosalVaccineAgainstCoxsackievirusB3byOptimizingtheCo-administrationModeofLymphotactinAdjuvant.DNACellBiol.2012Apr;31(4):479-88.GuiJ,YueY,XuW,ChenR,XiongS.A20(TNFAIP3)AlleviatesCVB3-InducedMyocarditisviaInhibitingNF-kBSignaling.PLOSOne.2012;7(9):e46515LvK,XuW,WangC,NikiTo;HirashimaMi,XiongS.Galectin-9administrationamelioratesCVB3inducedmyocarditisbypromotingtheproliferationofregulatoryTcellsandalternativelyactivatedTh2cells.ClinImmunol.2011;Jul;140(1):92-101YueY,GuiJ,AiW,XuW,XiongS.DirectGeneTransferwithIP-10MutantAmelioratesMouseCVB3-inducedMyocarditisbyBluntingTh1ImmuneResponses.PLoSOne.2011;Mar22;6(3):e18186YueY,GuiJ,XuW,XiongS.GenetherapywithCCL2(MCP-1)mutantprotectsCVB3-inducedmyocarditisbycompromisingTh1polarization.MolImmunol.2011:48:706-713LiK,XuW,GuoQ,JiangZ,WangP,YueY,XiongS.DifferentialmacrophagepolarizationinmaleandfemaleBALB/cmiceinfectedwithcoxsackievirusB3definessusceptibilitytoviralmyocarditis.CirculationRes.2009;105:353-364.YueY,XuW,HuL,JiangZ,XiongS.EnhancedresistancetocoxsackievirusB3-inducedmyocarditisbyintranasalco-immunizationoflymphotactingeneencapsulatedinchitosanparticle.Virology.2009;386:438-447.ShenY,KanQC,XuW,XiongS.CoxsackievirusB3infectioninducedviralmyocarditisbyregulatingtheexpressionpatternofchemokinesincardiacmyocytes.IranJAllergyAsthmaImmunol.2009Mar;8(1):1-9.JiangZ,XuW,LiK,YueY,XuL,YeF,XiongS.RemissionofCVB3-inducedviralmyocarditisbyinvivoTh2polarizationviahydrodynamics-basedIL-4genetransfer.JGeneMed.2008;Aug;10:918-929.ShenY,XuW,ChuY,WangY,LiuQ,XiongS.CVB3infectionup-regulatestheexpressionofMCP-1incardiacmyocyteswhichleadstoenhancedmigrationofmononuclearcellsinviralmyocarditis(VMC).J.Virol.2004;78(22)：12548-12556.XuW,ShenY,JiangZ,WangY,ChuY,XiongS.IntranasalDeliveryofChitosan-DNAVaccineGeneratesMucosalSIgAandanti-CVB3Protection.Vaccine.2004;22(27-28):3603-3612,Answerfromthechiefeditor:,DearDrXuandProfXiong,ManythanksforyourprovidingtheCVandpublicationsaswellasresearchinformation.Afterdiscussionbetweentheeditorialstaffwerecommendyoutopreparethisreviewpaper.Attachedpleasefindtheauthorinstructionsandtheexamplecoverletterforyourconsideration.Thelengthforreviewpaperis6000-8000wordsand4-6figures.Whatshouldbepointedoutisthatyourpaperwillgothroughtheprocessofqualitycheck,assesmentbeforereviewandpeerreviewbeforemakingdecisionofacceptance,revisionorreject.Pleasedonothesitatetoletusknowifyouhaveanyquestion.Thanks.EditorCellularActaVirol47,253-257(2003),andviralloadincreasedafterday3intheintestineandheartwhilethatdrasticallydecreasedinotherorgansafteraninitialviralpeakonday3MicrobesInfect11,493-499(2009)indicatingtheintestineaswellastheheartarebothimportanttissuesforCVB3replicationandactivity.”,Example5:,4.GeneraltheauthorsbroadlyshowedhowCVB3infectionaffectedseveralimmunecellsinthehost.However,theydidnotmakeanymentionoftheactivationandinfluencemechanisms.CVB3infectioncanindirectlyaffecttheimmunesystemofhosts,however,somestudieshaveshownthatCVB3infectioncandirectlyinfluenceimmunecells.Iftheauthorsagreewiththisfinding,thentheyshouldhaveraisedthepossibilitythatCVB3candirectlyinfectimmunecells,andinparticularTcells.SomepapershavealreadyshownthatCVB3candirectlyinfectimmunecells(includingTcells)andinfluencesignalingpathwaysinTcellsforactivation.Pleasesee:Interviology.2012;55(5):333-41JImmunol.2010Oct1;185(7):4004-10.Epub2010Aug27.JImmunol.2011Sep15;187(6):3451-2.JClinInvest.2002Jun;109(12):1561-9.VirusGenes.2012Apr;44(2):176-82.).Inthisregard,theauthorsshouldmentionpaperswhichshowthatCVB3candirectlyinfluenceTcellactivationviaERK,LckandSyk,orsomeviralspecificparts(ITAM-likesequences).ThesepartsmaybevaluableinshowingthemechanismsforCVB3-inducedTcellactivation.Pleaseaddressthisinthemanuscript.Authorresponse:Thankyouverymuchforyourcomments.Paragraphdescribingthisviewpointas“HowdoesCVB3activateTimmuneresponse?IthasbeenreportedthatCVB3coulddirectinfectimmunecellsandinteractwithsignaltransductionmoleculetofacilitateviraldisseminationandTcellactivation.ActivereplicationofCVB3wasfoundinhumanleukocytelineages,includingB,TcellandmonocyteIntervirology.2012;55(5):333-41.TrafficofsplenicBcellswithCVB3replicationmaycontributetomaintenanceofchronicdiseaseLabInvest78,1227-1237(1998);VirusRes62,149-158(1999).CVB3couldactivateERKdownstreamofLckwhichisnecessaryforefficientCVB3replicationandTactivationJClinInvest.2002Jun;109(12):1561-9.ITAM-likesequencesinVP2affectCVB3proliferationinTcellsviaSyk-signalingpathwayandregulateNF-KBactivationandproinflammatorycytokineinductioninmacrophageswhichaffectviralpathogenesisVirusGenes.2012Apr;44(2):176-82.”hasbeenaddedintherevisedmanuscript.Reference(JImmunol.2010Oct1;185(7):4004-10.)suggestthatTh17cellscontributetoCVB3replication,soIhavenotaddedthiscontentintheparagraph.,Peer-reviewer2comments.4.General:Icouldntseeanymentionoftherefer